Factors influencing the virulence of Candida Spp

West Indian Medical Journal

Volumn 58, Issue 2, 2009, Pages 160-163

  Melo Coutinho, H D ^a  

^a REGIONAL UNIVERSITY OF CARIRI   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; ENZYME; TOXIN;

ARTICLE; CANDIDA; CANDIDIASIS; ENVIRONMENT; ENVIRONMENTAL CHANGE; FUNGAL VIRULENCE; HEALTH CARE PERSONNEL; HOST PARASITE INTERACTION; INFECTION RISK; KNOWLEDGE; MEDLINE; NONHUMAN; PUBLICATION;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CANDIDIASIS; HOST-PATHOGEN INTERACTIONS; HUMANS; RISK FACTORS; VIRULENCE;

EID: 70049099658     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Batista JM, Birman EG, Cury AE. Susceptibility to antifungal drugs of Candida albicans strains isolated from patients with denture stomatitis. Rev Odontol Univ São Paulo 1999; 13: 343-348
2. De Bernardis F, Mondello F, San Millàn R, Pontòn J, Cassone A. Biotyping and Virulence Properties of Skin Isolates of Candida parapsilosis. J Clin Microbiol 1999; 37: 3481-3486 (Pubitemid 29491078)
3. De Bernardis F, Mühlschlegel FA, Cassone A, Fonzi WA. The pH of the Host Niche Controls Gene Expression in and Virulence of Candida albicans. Infect Immun 1998; 66: 3317-3325 (Pubitemid 28303132)
4. Boatto HF, Moraes MS, Machado AP, Girão MJBC, Fischman O. Relationship of laboratory results with clinical signs and symptoms of patients with vulvovaginal candidiasis and the significance of the sexual partners for the maintenance of the infection. Rev Bras Ginecol Obstet 2007; 29: 80-84
5. Cavassani VGS, Andrade-Sobrinho J, Homem MGN, Rapoport A. Oral candidiasis as prognostic marker of HIV-infected patients. Rev Bras Otorrinolaringologia 2002; 68: 630-634 (Pubitemid 37328102)
6. Colombo AL,Guimarães T. Epidemiology of hematogenous infections due to Candida spp. Rev Soc Bras Med Trop. 2003; 36: 599-607. Epub 2003 Oct 21.
7. Coutinho HDM, Bezerra DAC, Lôbo K, Barbosa IJF. Antimicrobial activity of natural products. Conceitos 2004; 10: 77-85.
8. Henning MM, Perrone M. Factores Determinantes de Patogenicidad em Relacion a la Ecologia de Candida albicans em cavidad bucal. Acta Odontol. Venez 2001; 39: 1-15.
9. Kontoyiannis DP, Lewis RE. Antifungal drug resistence of pathogenic fungi. Lancet 2002; 359: 1135-1144 (Pubitemid 34270742)
10. Lane S, Birse C, Zhou S, Matson R, Liu H. DNA Array Studies Demonstrate Convergent Regulation of Virulence Factors by Cphl, Cph2, and Efg1 in Candida albicans. J Biol Chem 2001; 276: 48988-48990 (Pubitemid 37370602)
11. a ed. São Paulo:Editora Manole Ltda, 1999.
12. a ed. Rio de Janeiro: Guanabara Koogan, 2000.
13. Neves RP, Cavalcanti MAQ, Chaves GM, Magalhães OMC. Yeasts isolated from clinical samples of AIDS patients. Braz J Microbiol 2002; 33: 363-364
14. Oliveira EE, Silva SC, Soares AJ, Attux C, Cruvinel B, Silva MRR. Killer toxin sensitiviy and production of enzymes by Candida albicans isolated from the oral mucosa of patients with cancer. Rev Soc Bras Med Trop 1998; 31: 1-2. (Pubitemid 28541357)
15. de Holanda AA, Fernandes AC, Bezerra CM, Ferreira MA, de Holanda MR. Vulvovaginal candidiasis: symptomatology, risk factors and concomitant anal colonization. Rev Bras Ginecol Obstet 2007; 29: 3-9.
16. Silva W, Diaz MCJ, Febré N. Vigilancia de la resistencia de levaduras a antifungicos. Rev Chi Infectol 2002; 19(suppl. 2): 1-3.
17. Uip DE, Strabelli TMV. Candidíase Esofagiana. Rev Bras Med Trop 2000; 57: 1294.
18. Weinfeld I, Birman EG, Paula CR. Macrophage phagocytosis of Candida albicans. An in vitro study. Rev Odontol Univ São Paulo, 1999; 13: 1-10.
19. Wu T, Wright K, Hurst SF, Morrison CJ. Enhanced Extracellular Production of Aspartyl Proteinase, a Virulence Factor, by Candida albicans Isolates following Growth in Subinhibitory Concentrations of Fluconazole. Antimicrob Agents Chemother, 2000; 44: 1-2. (Pubitemid 30228295)